Daito Pharmaceutical Co.,Ltd. (4577.T) JPX

Currency In JPY

AD

Valuation

Market Cap34.21B
Enterprise Value42.55B
P/E Ratio12.18
PEG Ratio0.17
Price/Sales Ratio0.74
Price/Book Ratio0.72
Enterprise/Revenue0.91
Enterprise/EBITDA6.13

Fiscal Year

Fiscal YearMay 31, 2026
Most Recent QuarterMay 31, 2026

Profitability

Profit Margin0.06
Operating Margin0.07
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.06

Income Statement

Revenue50.65B
Revenue/Share1,752.96
Gross Profit9.9B
EBITDA8.02B
Net Income3.16B
Diluted EPS107.46

Balance Sheet

Total Cash954M
Total Cash/Share33.02
Total Debt9.29B
Total Debt/Equity0.18
Current Ratio2.62
Book Value Per Share1,832.32

Price History

52-Week Change9.82
52-Week High1,521
52-Week Low1,120
Moving Average 50 Days1,306
Moving Average 200 Days1,321.14

Statistics

Average Volume73,028
Shares Outstanding28.74M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate40
Trailing Annual Dividend Yield3.06
Payout Ratio0.35
Last Split Factor2:1
Last Split DateMay 29, 2025
AD